Secondary Logo

Journal Logo

June 2010 - Volume 30 - Issue 3
pp: 223-354


A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia

Pandina, Gahan J.; Lindenmayer, Jean-Pierre; Lull, Julia; More

Journal of Clinical Psychopharmacology. 30(3):235-244, June 2010.

Early Adverse Events and Attrition in Selective Serotonin Reuptake Inhibitor Treatment: A Suicide Assessment Methodology Study Report

Warden, Diane; Trivedi, Madhukar H.; Wisniewski, Stephen R.; More

Journal of Clinical Psychopharmacology. 30(3):259-266, June 2010.

Two-Year Outcome of Vagus Nerve Stimulation in Treatment-Resistant Depression

Bajbouj, Malek; Merkl, Angela; Schlaepfer, Thomas E.; More

Journal of Clinical Psychopharmacology. 30(3):273-281, June 2010.


Tapering Clonazepam in Patients With Panic Disorder After at Least 3 Years of Treatment

Nardi, Antonio E.; Freire, Rafael C.; Valença, Alexandre M.; More

Journal of Clinical Psychopharmacology. 30(3):290-293, June 2010.

A Pooled MADRS/IDS Cross-Correlation Analysis: Clinician and Patient Self-Report Assessment of Improvement in Core Depressive Symptoms With Adjunctive Aripiprazole

Reimherr, Frederick W.; Martin, Michael L.; Eudicone, James M.; More

Journal of Clinical Psychopharmacology. 30(3):300-305, June 2010.


Olanzapine in Male and Female Adolescent Patients With Schizophrenia and Related Disorders: Minor Sex Differences in Outcomes

Dittmann, Ralf W.; Meyer, Eberhard; Freisleder, Franz Joseph; More

Journal of Clinical Psychopharmacology. 30(3):328-331, June 2010.


Show: